Nitto Avecia’s cover photo
Nitto Avecia

Nitto Avecia

Pharmaceutical Manufacturing

Milford, MA 13,083 followers

Comprehensive oligo solutions, from concept to commercial.

About us

Oligonucleotides are giving rise to a new generation of therapeutics—and Nitto Avecia is helping lead the way. With more than 30 years’ experience in oligonucleotide development and production, we are the partner of choice for pharmaceutical innovators creating new drugs with the power to transform treatment for a wide range of diseases.

Industry
Pharmaceutical Manufacturing
Company size
501-1,000 employees
Headquarters
Milford, MA
Type
Privately Held
Specialties
Custom Oligonucleotide Manufacture (pre-clinical to commercial), Analytical Services, Process Validation (oligonucleotide), and Stability Services

Locations

Employees at Nitto Avecia

Updates

  • We're looking forward to attending the Bioprocessing Summit in Boston, August 10–13! If you're seeking a strategic CDMO partner to support your biopharmaceutical and analytical development programs, we'd love to connect. Visit us at Booth #207 and meet our business development team: Keri Dufault Associate Vice President, Business Development Alyssa Uhlmansiek Senior Director, Business Development Theresa Vaughan Director, Business Development Laura Scully Director, Business Development

  • Sometimes innovation starts with the smallest things. At our Milford, Massachusetts campus, team members recently came together to care for our pollinator garden, a space inspired by an idea from our own Danica Rose and brought to life through the collective efforts of our Avecia Cares team. This is a welcome space for employees while supporting local biodiversity. Last week we gave the picnic table a nice coat of yellow paint. These moments reflect something bigger than landscaping. They reflect our commitment to environmental stewardship and to building a workplace where people and nature can thrive together. We were especially pleased to have our Executive Chairman, Fumiteru Asai, join us for the day, reinforcing that sustainability is a shared commitment across every level of our organization. At Nitto Avecia, our mission extends beyond advancing therapies. We also strive to be responsible stewards of our environment and our communities, supporting the values that guide the Nitto Group every day. Thank you to everyone who volunteered their time and energy to make our campus a little greener!

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
  • Innovation isn’t just about new ideas, it’s about continuously finding better ways to work, improve, and serve our customers.   Through Nitto’s GATE (Group Activities Towards Excellence) program, teams across our organization are turning ideas into meaningful improvements in quality, compliance, efficiency, and capabilities.   Congratulations to the Nitto Avecia Pharma Services teams, recognized for their outstanding projects and commitment to operational excellence. Their work reflects the collaboration and continuous improvement mindset that helps us deliver better outcomes for our customers and, ultimately, for patients.   Thank you to everyone who participated and continues to bring new ideas forward!

    • No alternative text description for this image
  • At Nitto Avecia, some of our best ideas come from the people closest to the work.   Through Nitto's GATE (Group Activities Towards Excellence) program, employees are empowered to drive innovation, collaboration, and continuous improvement across manufacturing, quality, operations, sustainability, and safety.   Recently, our Cincinnati, Ohio team recognized the outstanding projects that are helping strengthen our operations and culture. Congratulations to this year's GATE Excellence winners:   🥇 1st Place: Human-Centered SOP Renovation for Operational Reliability 🥈 2nd Place: One-Stop Shipping   Thank you to everyone who participated and shared ideas that make a meaningful impact. Every improvement—big or small—helps move Nitto Avecia forward and reinforces our commitment to excellence.

  •   Every great idea starts with people who see an opportunity to make a difference. Our parent company, Nitto Denko Corporation, empowers employees to participate in GATE – (Group Activities Towards Excellence), an initiative that encourages innovation, collaboration, and continuous improvement across the organization. Last week, our Milford site, led by Brian Murphy, MBA, LSSBB, showcased the outstanding work of teams who are driving meaningful improvements throughout Nitto Avecia. Employees had the opportunity to vote for their favorite project, creating strong engagement and a shared commitment to making our workplace safer, more sustainable, and more efficient.   Congratulations to this year’s Milford GATE winners:   Safety • First Aid Committee • SAFE Council   ESG • World Culture Day Committee • Earth Day Committee   Excellence • Manufacturing Kitting Team Process Improvement • SAP Raw Material Data Packets   Innovation isn't always about breakthrough technologies. Often it’s the everyday improvements, driven by dedicated employees, that strengthen our operations and build a culture of continuous improvement. Congratulations to all of our GATE teams for your creativity, collaboration, and commitment to excellence!

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
      +2
  • Congratulations to Phio Pharmaceuticals Corp. on reaching this important milestone in the advancement of PH-762.   We are proud to support the manufacture of the first commercial-scale cGMP batch of PH-762 drug substance as Phio advances its lead candidate into the next phase of development. This achievement reflects the dedication of both teams and the progress being made toward bringing innovative RNA-based therapies to patients.   We are grateful for the opportunity to partner with Phio and look forward to supporting the continued development of this promising program. https://lnkd.in/eMFhgicp

    • No alternative text description for this image
  • The Nitto Avecia Pharma Services team will be at CPHI Americas June 2-4. Alyssa Uhlmansiek and Theresa Vaughan will be manning booth #1620 at the conference to discuss how our analytical and scientific services support pharmaceutical and biotechnology programs from development through commercialization. Our President Tammy Cooper will also be attending the conference to connect with industry colleagues and gain insights into the latest trends and developments shaping the pharmaceutical and biotechnology landscape.    Whether you’re looking for cGMP analytical testing, extractables & leachables support, microbiology testing, biopharma analytics, or stability studies, our team is ready to explore how we can help keep your program on track. 📍 Pennsylvania Convention Center — Philadelphia, PA 📅 June 2–4, 2026 📌 Booth #1620 We look forward to connecting with industry partners and advancing safe therapies for patients together.

    • No alternative text description for this image

Similar pages

Browse jobs